Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of tetrasodium 8,8'-(1E,1'E)-(4,4'-(cyclohexane-1,1-diyl)bis(4,1-phenylene))bis(diazene-2,1-diyl)bis(7-hydroxynaphthalene-1,3-disulfonate) and trisodium 7-hydroxy-8-((E)-(4-(1-(4-((E)-(1-hydroxy-4-sulfonatonaphthalen-2-yl)diazenyl)phenyl)cyclohexyl)phenyl)diazenyl)naphthalene-1,3-disulfonate
EC number: 942-692-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- constituent 1
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Remarks:
- The complete Read Across Approach is attached at section 13. Source study has reliability 1.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 973
- Report date:
- 1973
Materials and methods
- Principles of method if other than guideline:
- In order to determine the dose/response relationship of the test substance, groups of 5 male and 5 female rats were dosed with various single doses (i.e. 1000, 3000, 6000, 10000 and 15000 mg/kg) of the compound, diluted in distilled water by gavage. Symptoms and mortality after administration were recorded during an observation period of 15 days. The LD50 was calculated by probit analysis method.
- GLP compliance:
- no
- Remarks:
- pre GLP
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Similar Substance 01
- IUPAC Name:
- Similar Substance 01
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Tif RAI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: young, unspecified.
- Weight at study initiation: 100 g.
- Housing: animals were housed in groups of 5 in macrolon cages (Size 3).
- Fasting period before study: fasted overnight.
- Diet: standard diet of Nafag, ad libitum.
- Water: drink water, ad libitum.
- Acclimation period: at least 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 1 °C
- Relative humidity: 55 ± 5 %
- Photoperiod: 12 hours cycle dark/light.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 1000, 3000, 6000, 10000 and 15000 mg/kg
- No. of animals per sex per dose:
- 5 × sex × doses
- Details on study design:
- - Duration of observation period following administration: 15 days.
- Frequency of observations and weighing: symptoms and mortality were monitored but the frequency was not specified. - Statistics:
- The LD50 was calculated by probit analysis method (maximum likelyhood, Goulden A., Methods of Statistical Analysis, John Wiley and Sons, 1960, 3rd printing, pages 404-408).
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 955 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 960 - 6 200
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 459.5 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- One female died at 1000 mg/kg after two days from the tretment.
At 6000 mg/kg 3 males and 3 females died.
At the doses of 10000 and 15000 mg/kg all animals died after 1 day from the substance administration. - Clinical signs:
- Reduction in spontaneous motility, slight ataxia, diarrhea, ditto and hypoventilation were recorded.
Any other information on results incl. tables
Dose mg/kg | Vehicle | Concentration (%) | Mortality | Bodyweight (g) | Symptoms | ||||
Absolute | % | Day of test | Pre-test | On day 15th | |||||
M | F | ||||||||
1000 | Distilled water | 10 | 0/5 | 0/5 | 0 | - | 100 | 206 | none |
3000 | Distilled water | 10 | 0/5 | 1/5 | 10 | 2 | 100 | 185 | transient reduction in spontaneous motility |
6000 | Distilled water | 10 | 3/5 | 3/5 | 60 | 2-4 | 100 | 228 | reduction in spontaneous motility, slight ataxia, diarrhea, |
10000 | Distilled water | 10 | 5/5 | 5/5 | 100 | 1 | 100 | - | ditto, hypoventilation |
15000 | Distilled water | 10 | 5/5 | 5/5 | 100 | 1 | 100 | - | ditto |
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified, according to the CLP Regulation (EC 1272/2008)
- Conclusions:
- LD50 is 4955 mg/kg, equivalent to 4459.5 mg/kg as a.i.
- Executive summary:
Method
The substance was tested for acute toxicity by oral route. Rats of both sexes were tested at concentration of 1000, 3000, 6000, 10000, 15000 mg/kg, by oral intubation. Physical condition and rate of death were monitored throughout the whole observation period.
Results
The symptoms during the 15 days of observation period were: reduction in spontaneous motility, slight ataxia, diarrhea, ditto, hypoventilation. The acute oral LD50 in rats was calculated to be 4955 mg/kg, equivalent to 4459.5 a.i.. Thus, the compound shows practically no acute toxicity to the rat by this route of administration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.